How to help patients cope with a chronic and life-threatening disease?
Novo Nordisk is a world leader in the treatment of diabetes, a complex disease with multiple factors and entail treatment that goes far beyond periodic insulin injections. To properly treat diabetes, medical specialists and patients need to continually share data on various aspects of the disease and its effect on the patient, and change the behaviour of patients as much as treat directly the disease.
Working with Novo Nordisk, Valtech built a Community Platform allowing patients, families, and doctors to work together and exchange critical information about the disease and its effects on the patient. As a result, proper treatment and the effect on lifestyle can be adjusted regularly. Valtech worked on all aspects of the community platform: from strategy to its technical and graphic design to implementation.
Today, the Community Platform is sponsored by several local diabetes associations and can be found in 16 countries.